CNS Pharmaceuticals (CNSP) Q1 2024 Annual Earnings
CNSP·Reported May 15, 2024·Before market open
Diluted EPS came in at $-12304.92.
Diluted EPS
$-12304.92
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about CNS Pharmaceuticals's Q1 2024 earnings report.
CNS Pharmaceuticals (CNSP) reported Q1 2024 earnings on May 15, 2024 before market open.
CNS Pharmaceuticals reported diluted EPS of $-12304.92 for Q1 2024.
You can read the 10-K periodic report (0001683168-24-002032) directly on SEC EDGAR. The filing index links above go to sec.gov.